501(c)3 transforming how LongCovid, ME/CFS, Lyme+ and Alzheimer’s are studied, diagnosed, and treated. Leading the #LongCovid Research Consortium.
United States
- Tweets 2,892
- Following 2,049
- Followers 14,385
- Likes 3,592
Pinned Tweet
From Crisis to Cure: PolyBio is supporting top HIV researchers to pivot into the study and treatment of Long COVID. Watch the full video to learn how this collaboration is being maximized & driving forward innovative research: piped.video/6kC1lyY6hPc?si=adTg…
20
172
531
81,725
Breaking: Steve and Judy Pagliuca and Governor Maura Healey Accelerate Major Effort to Deliver Treatments for Long COVID
$15 million raised by a coalition of donors to advance diagnostics and clinical trials for Long COVID; with the infrastructure expanding into chronic Lyme disease
1/
ALT Photos above from left to right: Governor Maura Healey; Steve Pagliuca; Drs. Amy Proal and Mike VanElzakker; Dr. Amy Proal and PolyBio Board member Jessica White. Photo credit: Josh Qualls, Director of Photography, Office of Governor Healey.
9
29
106
2,962
The clinical research infrastructure developed through LCCI is also being expanded to include patients with chronic Lyme disease and other infection-associated chronic conditions.
15/end
prnewswire.com/news-releases…
2
11
231
*Please note that COVID protections were prominent at the event. Germicidal far-UVC lights loaned to PolyBio via the OSLUV project were installed across the event space. LEVOIT Smart Air HEPA filters were also placed throughout the entire room. All guests were asked to take a COVID rapid antigen test and confirm negative status before the event. COVID tests and N95 masks were also available at the door to the venue.
Read more about the OSLUV project: osluv.org
15
229
Calling all ME/CFS and chronic Lyme disease patients living in the U.S.—we are recruiting a final few patients for a decentralized trial of the enzyme Lumbrokinase!
If eligible, the trial team will send the Lumbrokinase directly to your home (U.S. only). You will be required to track your symptoms via questionnaires over the study period.
Interested in participating? Email CoreResearch@MountSinai.org to apply now for this open-label trial.
Participants should:
-be 18 years or older
-live in the United States
-have a formal diagnosis from a physician of ME/CFS or Post-Treatment Lyme disease (PTLD)
2
22
51
2,457
Stay ahead of the curve on the research you care about.
PolyBio Research Foundation publishes a newsletter every month with access to our latest articles, summaries of research findings, and exciting interviews with partner researchers.
Join the list now ahead of our September launch: polybio.org/newsletter/
1
8
23
1,269
Drawing on expertise in engineering and microfluidics, Dr. Shannon Stott and her team developed a microfluidic chip that uses laboratory-produced ACE2 receptors to capture SARS-CoV-2 viral particles from biofluids.
Initially evaluated using blood samples from individuals with acute COVID-19, the "Herringbone" chip demonstrated the ability to detect viral loads as low as three viral copies per milliliter of blood.
The technology is now being evaluated in Long COVID biofluids as a potential method for detecting persistent SARS-CoV-2. Dr. Stott's team has received a second round of samples from the LIINC collaborative, advancing validation efforts as part of PolyBio's VIPER Diagnostics program.
2
29
79
5,566
3/ For Long COVID samples processed, the team will also evaluate if there is any correlation between clinical symptoms and virus levels; while also being evaluated against other SARS-CoV-2-detecting technologies within the VIPER program.
polybio.org/viper/
1
2
11
321
4/ Watch Dr. Stott’s full presentation from PolyBio’s Spring 2026 symposium: piped.video/tD5gWVEjudQ?t=10667…
3
10
402